Navigation Links
BioMarin Announces Second Quarter 2011 Financial Results
Date:7/28/2011

NOVATO, Calif., July 28, 2011 /PRNewswire/ --Financial Highlights ($ in millions, except per share data, unaudited)ItemQ2 2011Q2 2010 ComparisonTotal BioMarin Revenue

$110.6

20.2% increase Total Net Product Revenue

$109.6

21.0% increaseNaglazyme Net Product Revenue

$60.3

27.5% increaseAldurazyme BioMarin Net Product Revenue*

$17.3

$17.5Kuvan Net Product Revenue

$28.8

16.6% increaseFirdapse Net Product Revenue

$3.2

$1.1GAAP Net Income (Loss)

$(5.1)

$(0.5)GAAP Net Income (Loss) per share

$(0.05) (basic and diluted)

$(0.00) (basic), $(0.01) (diluted)Non-GAAP Adjusted EBITDA

$13.9

$17.5Non-GAAP Adjusted EBITDA per share

$0.13 (basic), $0.12 (diluted)

$0.17 (basic), $0.15 (diluted)   * Net product transfer revenue had no impact on net Aldurazyme revenue to BioMarin in the second quarter of 2011 and a negative $0.2 million impact on net Aldurazyme revenue to BioMarin in the second quarter of 2010.

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced financial results for the second quarter of 2011. GAAP net loss was $5.1 million ($0.05 per diluted share) for the second quarter of 2011, compared to GAAP net loss of $0.5 million ($0.01 per diluted share) for the second quarter of 2010.  Non-GAAP adjusted EBITDA was $13.9 million ($0.12 per diluted share) for the second quarter of 2011, compared to non-GAAP adjusted EBITDA of $17.5 million ($0.15 per diluted share) for the second quarter of 2010.  Non-GAAP adjusted EBITDA excludes depreciation and amortization, contingent consideration expense, interest income and expense, income taxes, stock compensation expense and material non-recurring items.  The reconciliation of the non-GAAP measures to the comparable GAAP measure is detailed in the table provided near the end o
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. BioMarin Announces FDA Approval for Kuvan
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015   NineSigma the leading ... over $450M in estimated overall revenue growth and anticipates the ... Third Frontier Open Innovation Incentive (OII). In ... NineSigma a grant of over $2 million to accelerate adoption ... between $10 Million and $1 Billion in revenues. To date ...
(Date:8/27/2015)... 2015 The nation,s newest Actos trial gets underway ... Vegas courtroom.  Attorneys representing two southern ... effects, including death, after using the diabetes drug Actos. ... a company knew, that their drug Actos caused an increased ... "In order to hold Takeda responsible it is appropriate to ...
(Date:8/27/2015)... CAESAREA, Israel , August 27, 2015 ... Equity today announced a private investment in public equity ... up to $28.4 million in Itamar Medical.   ... the largest shareholder of Itamar Medical and will work ... market expansion. According to the investment agreement, ...
Breaking Medicine Technology:State of Ohio and NineSigma Collaborate to Drive Regional Economic Growth and Job Creation 2State of Ohio and NineSigma Collaborate to Drive Regional Economic Growth and Job Creation 32 Billion Dollar Verdict Sought In Actos Trial 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5
... Holdings, Inc. (NYSE: ZMH ; SIX: ZMH) today ... the 26th North American Spine Society Annual Meeting in Chicago, ... waist providing clinicians with clear and direct visualization during implant ... 2mm) which clinical literature suggests is one of the factors ...
... Inc. (Hologic or the Company) (NASDAQ: HOLX ... diagnostics products, medical imaging systems and surgical products dedicated ... that it has appointed Christiana Stamoulis to the Company,s ... on the Company,s Corporate Development Committee. Ms. ...
Cached Medicine Technology:Zimmer Introduces inViZia™ Anterior Cervical Plate System at NASS Annual Meeting 2Zimmer Introduces inViZia™ Anterior Cervical Plate System at NASS Annual Meeting 3Hologic Announces Appointment of New Director 2
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... ... confirmed today that its Krames Patient Education content is ICD-10 ready and available ... ready for the new ICD-10 code sets, which are more targeted and return ...
(Date:8/27/2015)... ... August 27, 2015 , ... Zensah®, the ... professional Tennis player for Israel in the Women’s Tennis Association (WTA). Glushko competes ... training and recovery. , With a focus on technology and comfort, Zensah® has ...
(Date:8/27/2015)... ... August 27, 2015 , ... In addition to its existing Doctor of Philosophy ... doctoral program at its main campus in Reading: Doctor of Nursing Practice. , Alvernia’s ... prepare advanced practice nurses for the highest level of clinical nursing practice. , ...
(Date:8/27/2015)... CT and OKLAHOMA CITY, OK (PRWEB) , ... ... ... Great Point Partners (“GPP”) I, LP portfolio company and leading biopharmaceutical contract development ... to be acquired by Hepalink USA Inc. (“Hepalink”) for $205.68M in cash. ...
(Date:8/27/2015)... ... August 27, 2015 , ... Market ... market research promotion on the Internet. MarketPublishers.com is now authorised to distribute ... the partnership agreement, Natalie Aster, Assistant Manager at Partners Department, noted: "Black ...
Breaking Medicine News(10 mins):Health News:StayWell announces all health content is ICD-10 ready 2Health News:StayWell announces all health content is ICD-10 ready 3Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3
... among those who drink 100% juice, but not all experts ... Children who drink 100 percent fruit juices apparently don,t tend ... than kids who don,t drink the beverages, a new study ... children," said lead researcher Theresa A. Nicklas, a professor of ...
... June 3 The nonpartisan Employee,Benefit Research Institute ... estimates of the amount of money individuals and ... in retirement. The new estimates,attempt to provide more ... with the financial consequences of longevity and investment ...
... 67% Say Less Likely to Re-Elect Member of ... WASHINGTON, June 3 As Congress prepares to,reconvene ... the,American Health Care Association (AHCA) released the results ... that seventy percent of,likely U.S. voters oppose an ...
... Market competition is,mounting to win the time, attention ... research shows that the most sought-after,clinical investigation sites ... they receive at their labs and clinics. Consequently,leading ... the art,and science of investigator recruitment., The ...
... of Women Business Owners Members Voice Their,Opinions on National ... state of the,economy, the cost and availability of health ... are the top issues impacting the,women,s business community at ... the National Association of Women Business Owners(R),(NAWBO(R)) among its ...
... area , , TUESDAY, June 3 (HealthDay News) -- When ... system to target malignancies, it was hoped that the therapy ... without affecting healthy tissue. , While the original theory is ... effects. , The findings, published in the June 10 issue ...
Cached Medicine News:Health News:Fruit Juice May Be Healthy for Kids: Study 2Health News:Fruit Juice May Be Healthy for Kids: Study 3Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 2Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 3Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 4Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 5Health News:70% of U.S. Voters Oppose Administration's Cuts to Medicare-Financed Nursing Home Care 2Health News:Best Practice Toolkit Supports Recruitment of Top Clinical Investigators 2Health News:Economy, Health Care, and Gas Prices Top Issues for Women Business Owners 2Health News:Dangerous Side Effect Found in Cancer Immunotherapy Research 2
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... The Blue Line UNO Splint fits small, medium, ... cushioned two-part design includes both dorsal and volar ... extension. Recommended for those experiencing symptoms of Carpal ... for busy clinics - stock one splint to ...
Comfort Wrist Immobilizer with thumb abduction. 8"L, soft, padded comfort-type wrist immobilizer with dorsal metal stay. The thumb is held in abduction and splintered with a short metal stay....
Medicine Products: